Serban Georgescu, MD, MBA

Serban Georgescu, MD, MBA is a physician entrepreneur with a focus on digital health and medical technologies. He currently serves as the Senior Trade Officer for the Canadian Technology Accelerator and Digital Health at the Consulate General of Canada in Boston, a position he has held since 2018.1

Professional Background

Dr. Georgescu's career spans multiple roles across healthcare, technology, and business:

Medical and Research Experience::

• He has a background as a physician and scientist, having worked at Tufts Medical Center in various research capacities from 1998 to 2011.1
• His research focused on lipid metabolism, cardiovascular signaling, and molecular cardiology.1

Entrepreneurship and Business Development::

• Co-founder of NotoVox, Inc. since 2015, a company focused on improving medical coding for better quality and cost of care.12
• Held leadership positions in business development and marketing at companies like InfoBionic and Lighthouse Healthcare Partners.1

Advisory and Board Roles::

• Due Diligence Chair at Mass Medical Angels since 2011, evaluating early-stage life science companies for investment.1
• Advisory Board Member for New England Breath Technologies since 2016.1
• Founder of the Romanian American Biomedical Association in 2010.1

Current Role

As Senior Trade Officer at the Consulate General of Canada in Boston, Dr. Georgescu's responsibilities include:

• Connecting Canadian innovative digital health, life sciences, and tech companies to the New England market.1
• Facilitating partnerships with clients, partners, and investors in the region.1
• Supporting the growth of Canadian technology companies in the U.S. market.3

Education and Skills

Dr. Georgescu holds both an MD and an MBA, combining medical expertise with business acumen. He is proficient in multiple languages, including English, Romanian, Japanese (limited working proficiency), and Russian (elementary proficiency).1

His unique blend of medical knowledge, business skills, and international experience positions him well to bridge the gap between Canadian health technology innovators and the U.S. healthcare market.